Literature DB >> 23411922

Microsatellite instability--MSI markers (BAT26, BAT25, D2S123, D5S346, D17S250) in rectal cancer.

Graziele Moraes Losso1, Roberto da Silveira Moraes, Arthur C Gentili, Iara Taborda Messias-Reason.   

Abstract

BACKGROUND: Colorectal cancer has an important genetic component. Microsatellites are considered phenotypic markers of prognosis, therapeutic response and identify patients with mutations in DNA repair genes. AIM: To evaluate the molecular profile of tumors underwent to transanal endoscopic microsurgery-TEM in surgical treatment of rectal cancer.
METHOD: Thirty eight surgical specimens were evaluated according to pathological staging and the region of the tumor were dissected and submitted to DNA extraction. The colorectal tumors were tested for microsatellite instability-MSI using a panel of five markers (BAT25, BAT26, D2S123, D5S346, and D17S2720) technique of Polymerase Chain Reaction (PCR). RESULT: From total 63% were male and 47% female, with mean age of 58.4 years. In relation to tumor type adenomas were 58%, 24% low-grade adenomas and 76% high grade; 42% were carcinomas. The depth of resection 80% included the rectal perirenal fat and 20% the muscularis propria. The most frequent microsatellite amplification was BAT26 (100%) and lowest D17S2720 (85.4%). Sixteen patients (42%) were MSI, ten were carcinomas, two low grade adenomas and four high grade. Twenty-two cases (68%) showed microsatellite stable-MSS. The allelic loss of microsatellite markers was statistically significant in cases of carcinoma in relation to adenomas. The most frequent microsatellite amplification was BAT26 (100%) and lower D17S2720 (85.4%), 16 patients (42%) had microsatellite instability-MSI thereof ten were carcinomas, two low grade adenomas, four high-grade adenomas and 22 cases (58%) were microsatellite stable-MSS.
CONCLUSION: Microsatellite instability (MSI-H) was significantly associated with rectal carcinomas, confirming its use as a prognostic marker in colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23411922     DOI: 10.1590/s0102-67202012000400006

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


  9 in total

1.  Preferential allelic deletion of RBSP3, LIMD1 and CDC25A in head and neck squamous cell carcinoma: Implication in cancer screening and early detection.

Authors:  Shreya Sarkar; Chinmay Kumar Panda
Journal:  Cancer Biol Ther       Date:  2018-04-13       Impact factor: 4.742

2.  Microsatellite instability and protein expression of MLH1 and MSH2 genes in young Mexican patients less than 50 years of age diagnosed with colorectal cancer.

Authors:  Arturo Quintanilla-Guzman; Arturo Luevano-Gonzalez; Ada Nayeli Rangel-Gomez; Augusto Rojas-Martinez; Raquel Garza-Guajardo; Oralia Barboza-Quintana; Jesus Ancer-Rodriguez; Clara Patricia Rios-Ibarra; Rocio Ortiz-Lopez
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  Looking beyond the cytogenetics in haematological malignancies: decoding the role of tandem repeats in DNA repair genes.

Authors:  Priyanjali Bhattacharya; Trupti N Patel
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

Review 4.  Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.

Authors:  Fabio Coppedè; Angela Lopomo; Roberto Spisni; Lucia Migliore
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 5.  Current and future molecular diagnostics in colorectal cancer and colorectal adenoma.

Authors:  Andy Hin-Fung Tsang; Ka-Ho Cheng; Apple Siu-Ping Wong; Simon Siu-Man Ng; Brigette Buig-Yue Ma; Charles Ming-Lok Chan; Nancy Bo-Yin Tsui; Lawrence Wing-Chi Chan; Benjamin Yat-Ming Yung; Sze-Chuen Cesar Wong
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

6.  Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma.

Authors:  Watcharin Loilome; Sasithorn Kadsanit; Kanha Muisook; Puangrat Yongvanit; Nisana Namwat; Anchalee Techasen; Anucha Puapairoj; Narong Khuntikeo; Pichai Phonjit
Journal:  Oncol Lett       Date:  2016-12-08       Impact factor: 2.967

Review 7.  Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).

Authors:  Taxiarchis Konstantinos Nikolouzakis; Loukia Vassilopoulou; Persefoni Fragkiadaki; Theodoros Mariolis Sapsakos; Georgios Z Papadakis; Demetrios A Spandidos; Aristides M Tsatsakis; John Tsiaoussis
Journal:  Oncol Rep       Date:  2018-03-21       Impact factor: 4.136

8.  Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.

Authors:  Apostolos Zaravinos; Constantinos Roufas; Majdi Nagara; Beatriz de Lucas Moreno; Maria Oblovatskaya; Christodoulos Efstathiades; Christos Dimopoulos; Georgios D Ayiomamitis
Journal:  J Exp Clin Cancer Res       Date:  2019-08-20

Review 9.  Colorectal Cancer Screening: A Comprehensive Review to Recent Non-Invasive Methods.

Authors:  Leila Hamzehzadeh; Meysam Yousefi; Seyed-Hamidollah Ghaffari
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-07-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.